Pulmonx
LUNG1.6301.24% ( +0.020 )
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Preview: Pulmonx(LUNG) predict that the Revenue is 22.76 M (-4.62%), Beat estimate;the EBIT is -9.057 M (+38.82%), Beat estimate;the EPS is -0.24 (+36.84%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.02B4.62%
0.02B6.14%
+0.00B1.52%
EBITExceed expectations
-0.01B38.82%
-0.01B24.73%
+0.00B14.09%
EPSExceed expectations
-0.2436.84%
-0.2826.32%
+0.040010.52%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf